Lupus & Connective Tissue Diseases
Conference Coverage
Antimalarials prove protective against long-term lupus damage
Major finding: Patients with recently diagnosed SLE and no significant organ damage at baseline were 71% more likely to develop irreversible organ...
Conference Coverage
Cyclophosphamide and rituximab combo reduced severe lupus flares
Major finding: Patients with severe recurrent systemic lupus erythematosus collectively had 38 lupus flares, including 26 with renal involvement,...
News
Abatacept may reduce maintenance immunosuppression need in lupus nephritis
Major finding: Complete renal response rates were similar at 33% and 31% in treatment vs.
News
Novel predictor of poor outcomes in lupus pregnancies
Major finding: Pregnant patients with SLE and/or APS had nearly a 14-fold increased risk of developing preeclampsia before 34 weeks’ gestation...
News
Number of U.S. malaria cases hits 40-year high
Conference Coverage
Systemic sclerosis brings sharply increased MI risk
Major finding: The incidence rate of acute MI following diagnosis of systemic sclerosis was 20.2 events per 1,000 person-years, compared with 5.3...
Conference Coverage
Treatment adherence poor among Medicaid beneficiaries with lupus
Major finding: Among Medicaid beneficiaries with SLE, the average medication possession ratio ranged from 31.1% for tacrolimus to 56% for...
News
Common analgesics linked to flares of Crohn’s disease
Major finding: Patients with Crohn’s disease were 65% more likely to have an exacerbation if they used NSAIDs five or more times per month and 72...
Conference Coverage
Apremilast promising for Behçet’s syndrome
Major finding: The mean number of oral ulcers in Behçet’s syndrome patients treated with apremilast quickly dropped from 2.8 at baseline to 0.5,...
Conference Coverage
Systemic sclerosis overlap syndromes called distinct entity
Major finding: Musculoskeletal involvement occurred in 67% of patients with systemic sclerosis overlap syndromes, compared with 38% of those with...